Bioneer Corporation (KOSDAQ:064550)
11,920
+100 (0.85%)
At close: Mar 20, 2026
Bioneer Market Cap
Bioneer has a market cap or net worth of 307.66 billion as of March 20, 2026. Its market cap has decreased by -24.79% in one year.
Market Cap
307.66B
Enterprise Value
328.78B
Revenue
320.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,920.00
Market Cap Chart
Since December 29, 2005, Bioneer's market cap has increased from 157.77B to 307.66B, an increase of 95.01%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 307.66B | -6.51% |
| Dec 30, 2025 | 329.08B | -32.36% |
| Dec 30, 2024 | 486.52B | -43.39% |
| Dec 28, 2023 | 859.48B | 13.27% |
| Dec 29, 2022 | 758.82B | -39.51% |
| Dec 30, 2021 | 1.25T | 181.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 488.97B |
| SillaJen | 475.86B |
| Anterogen.Co.,Ltd. | 464.28B |
| BINEX | 414.02B |
| GC Cell | 398.97B |
| JETEMA, | 319.76B |
| HLB Therapeutics | 275.93B |
| Helixmith | 268.91B |